Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noone

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of the American Chemical Society|April 13, 2013
EPR and FTIR analysis of the mechanism of H2 activation by [FeFe]-hydrogenase HydA1 from Chlamydomonas reinhardtiiDavid W Mulder, Michael W Ratzloff, Eric M Shepard, et al.
Seminars in Oncology|October 31, 2001
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancerW D Figg, P Arlen, J Gulley, et al.
Translational Psychiatry|March 29, 2017
Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics studyK M Ryan, A Glaviano, S M O'Donovan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerJ S Fisherman, K H Cowan, M Noone, et al.
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Blood|March 15, 1996
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancerJ A O'Shaughnessy, A Tolcher, D Riseberg, et al.
British Journal of Haematology|March 1, 1996
Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrowG N Schwartz, F Hakim, J Zujewski, et al.
Frontiers in Microbiology|July 28, 2017
The Physiological Functions and Structural Determinants of Catalytic Bias in the [FeFe]-Hydrogenases CpI and CpII of <i>Clostridium pasteurianum</i> Strain W5Jesse B Therien, Jacob H Artz, Saroj Poudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluationsJ A Lawrence, P C Adamson, R Caruso, et al.
ACS Applied Materials & Interfaces|March 4, 2011
Surface characterization of polythiophene:fullerene blends on different electrodes using near edge X-ray absorption fine structureAndreas F Tillack, Kevin M Noone, Bradley A Macleod, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of the American Chemical Society|April 13, 2013
EPR and FTIR analysis of the mechanism of H2 activation by [FeFe]-hydrogenase HydA1 from Chlamydomonas reinhardtiiDavid W Mulder, Michael W Ratzloff, Eric M Shepard, et al.
Seminars in Oncology|October 31, 2001
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancerW D Figg, P Arlen, J Gulley, et al.
Translational Psychiatry|March 29, 2017
Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics studyK M Ryan, A Glaviano, S M O'Donovan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerJ S Fisherman, K H Cowan, M Noone, et al.
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Blood|March 15, 1996
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancerJ A O'Shaughnessy, A Tolcher, D Riseberg, et al.
British Journal of Haematology|March 1, 1996
Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrowG N Schwartz, F Hakim, J Zujewski, et al.
Frontiers in Microbiology|July 28, 2017
The Physiological Functions and Structural Determinants of Catalytic Bias in the [FeFe]-Hydrogenases CpI and CpII of <i>Clostridium pasteurianum</i> Strain W5Jesse B Therien, Jacob H Artz, Saroj Poudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluationsJ A Lawrence, P C Adamson, R Caruso, et al.
ACS Applied Materials & Interfaces|March 4, 2011
Surface characterization of polythiophene:fullerene blends on different electrodes using near edge X-ray absorption fine structureAndreas F Tillack, Kevin M Noone, Bradley A Macleod, et al.
Pageof 7